Tech article
Most powerful obesity drug yet: People lost up to 25% of weight in trial
Publisher description: Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Ars Technica | Sep 29, 2026 | Beth Mole
Tech article
Publisher description: Retatrutide is a triple-hormone obesity drug simulating GLP-1, GIP, and glucagon.
Ars Technica | Sep 29, 2026 | Beth Mole